Cargando…

Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation

Cancer cells alter metabolic processes to sustain their characteristic uncontrolled growth and proliferation. These metabolic alterations include (1) a shift from oxidative phosphorylation to aerobic glycolysis to support the increased need for ATP, (2) increased glutaminolysis for NADPH regeneratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiliro, Chelsea, Firestein, Bonnie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146072/ https://www.ncbi.nlm.nih.gov/pubmed/33946927 http://dx.doi.org/10.3390/cells10051056

Ejemplares similares

Correction: Schiliro, C.; Firestein, B.L. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells 2021, 10, 1056
por: Schiliro, Chelsea, et al.
Publicado: (2022)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming
por: Nishimura, Ken, et al.
Publicado: (2019)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
por: Sreedhar, Annapoorna, et al.
Publicado: (2018)

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
por: Navarro, Carla, et al.
Publicado: (2022)

Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022)

UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
por: Esteves, Pauline, et al.
Publicado: (2014)

Hypoxia-driven metabolic reprogramming of adipocytes fuels cancer cell proliferation
por: Aird, R., et al.
Publicado: (2022)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016)

Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021)

Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
por: Amrutkar, Manoj, et al.
Publicado: (2021)

Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023)

The role of noncoding RNAs in metabolic reprogramming of cancer cells
por: Safi, Amir, et al.
Publicado: (2023)

Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells
por: Seo, Jieun, et al.
Publicado: (2020)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

Evolutionary Origins of Metabolic Reprogramming in Cancer
por: García-Sancha, Natalia, et al.
Publicado: (2022)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
por: Zhao, Lin, et al.
Publicado: (2022)

Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
por: Feng, William W., et al.
Publicado: (2020)

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
por: Ge, Tongxin, et al.
Publicado: (2022)

Metabolic Reprogramming in Mitochondria of Myeloid Cells
por: Zuo, Hao, et al.
Publicado: (2019)

Metabolic Reprogramming in Tumor Endothelial Cells
por: García-Caballero, Melissa, et al.
Publicado: (2022)

Metabolic reprogramming by viruses in the sunlit and dark ocean
por: Hurwitz, Bonnie L, et al.
Publicado: (2013)

Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
por: Ohshima, Kenji, et al.
Publicado: (2021)

Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
por: Nenkov, Miljana, et al.
Publicado: (2021)

Novel drugs that target the metabolic reprogramming in renal cell cancer
por: van der Mijn, Johannes C., et al.
Publicado: (2016)

Metabolic Reprogramming and Its Regulatory Mechanism in Sepsis-Mediated Inflammation
por: Liu, Wenzhang, et al.
Publicado: (2023)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer
por: El-Sahli, Sara, et al.
Publicado: (2020)

Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells
por: Yao, Gebing, et al.
Publicado: (2019)

Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma
por: Vyas, Monika, et al.
Publicado: (2019)

Reprogramming of fatty acid metabolism in cancer
por: Koundouros, Nikos, et al.
Publicado: (2019)

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
por: Xu, Xuemeng, et al.
Publicado: (2023)

Metabolic reprogramming in cervical cancer and metabolomics perspectives
por: Li, Boning, et al.
Publicado: (2021)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_na91648r018kr9dim6aa3h58cq